COGT — Cogent Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Cogent Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	220	259	266	287	901
Prepaid Expenses
Total Other Current Assets
Total Current Assets	223	265	271	296	910
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.48	31.1	30.3	26.6	23.5
Long Term Investments
Other Long Term Assets
Total Assets	232	301	313	328	938
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	17.1	26.8	38.2	55.7	64
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.9	45.1	55.6	71.6	301
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	214	256	258	256	636
Total Liabilities & Shareholders' Equity	232	301	313	328	938
Total Common Shares Outstanding
Total Preferred Shares Outstanding